The efficacy of Narrow-Band Ultraviolet-B Therapy on Vitiligo patients
Anabar, T., El-Domyati, M., Abdel-Aziz, R., Mohammed., M. (2020). The efficacy of Narrow-Band Ultraviolet-B Therapy on Vitiligo patients. EKB Journal Management System, 31(2), 277-279. doi: 10.21608/mjmr.2022.221067
Tag El-Din S. Anabar; Moataz M. El-Domyati; Rasha Abdel-Aziz; Maysa Y. Mohammed.. "The efficacy of Narrow-Band Ultraviolet-B Therapy on Vitiligo patients". EKB Journal Management System, 31, 2, 2020, 277-279. doi: 10.21608/mjmr.2022.221067
Anabar, T., El-Domyati, M., Abdel-Aziz, R., Mohammed., M. (2020). 'The efficacy of Narrow-Band Ultraviolet-B Therapy on Vitiligo patients', EKB Journal Management System, 31(2), pp. 277-279. doi: 10.21608/mjmr.2022.221067
Anabar, T., El-Domyati, M., Abdel-Aziz, R., Mohammed., M. The efficacy of Narrow-Band Ultraviolet-B Therapy on Vitiligo patients. EKB Journal Management System, 2020; 31(2): 277-279. doi: 10.21608/mjmr.2022.221067

The efficacy of Narrow-Band Ultraviolet-B Therapy on Vitiligo patients

Minia Journal of Medical Research
Volume 31, Issue 2, April 2020, Page 277-279  XML PDF (270.61 K)
Document Type: Original Article
DOI: 10.21608/mjmr.2022.221067
View on SCiNiTO View on SCiNiTO
Authors
Tag El-Din S. Anabar1; Moataz M. El-Domyati2; Rasha Abdel-Aziz1; Maysa Y. Mohammed.1
1Department of Dermatology, Minia University, Minia, Egypt.
2Department of Dermatology, Minia University, Minia, Egypt
Abstract
Background: Vitiligo is an acquired depigmentation disorder of great cosmetic importance, affecting 
1% of the general population. Photochemotherapy is the most commonly used treatment modality in 
vitiligo, but is associated with many short and long-term side-effects. Narrow-band ultraviolet B (NBUVB) therapy has been reported to be an effective and safe therapeutic option in patients with vitiligo. 
Aim of wok: to explore the efficacy and safety of NB-UVB therapy in vitiligo patients. Patients and 
methods: twenty patients (eight males and twelve females), aged 15-56 years, with vitiligo, were 
treated twice weekly with NB-UVB phototherapy for a maximum period of 6 months. Results: At the 
end of 6 months, fourteen of twenty patients achieved more than 75% repigmentation, whereas 4 
patients showed 50% repigmentation and 2 patients showed 25% repigmentation after treatments. 
Adverse effects were limited and transient. Conclusion: NB-UVB therapy is effective and safe in 
patients with vitiligo. Long-term follow up is required to establish the stability of repigmentation.
Short-term adverse effects of NB-UVB include burning, pruritus and xerosis.

Keywords
Vitiligo; Narrow-band ultraviolet; safe therapeutic
Supplementary Files
Statistics
Article View: 54
PDF Download: 446